5 Best High Growth Healthcare Stocks to Buy

2. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Number of Hedge Fund Holders: 35

Cambridge, Massachusetts-based Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a leading biotechnology company focused on developing novel medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system and ocular diseases.

On November 2, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) released its financial results for Q3 2023. Its total income increased by 184% y-o-y to $751 million while it generated a net income of $148 million, compared to a net loss of $406 million in Q3 2022.

As of Q3 2023, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares, valued at $465 million, were owned by 35 of the 910 hedge funds tracked by Insider Monkey. Kurt Von Emster’s VenBio Select Advisor was at the top of this list with ownership of 1.0 million shares valued at $179 million.